19-41220680-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021913.5(AXL):āc.130A>Gā(p.Ile44Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,609,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021913.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AXL | NM_021913.5 | c.130A>G | p.Ile44Val | missense_variant | 2/20 | ENST00000301178.9 | |
AXL | NM_001699.6 | c.130A>G | p.Ile44Val | missense_variant | 2/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AXL | ENST00000301178.9 | c.130A>G | p.Ile44Val | missense_variant | 2/20 | 1 | NM_021913.5 | A2 | |
AXL | ENST00000359092.7 | c.130A>G | p.Ile44Val | missense_variant | 2/19 | 1 | P2 | ||
AXL | ENST00000599659.5 | n.144A>G | non_coding_transcript_exon_variant | 2/12 | 1 | ||||
AXL | ENST00000594880.1 | n.147A>G | non_coding_transcript_exon_variant | 2/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152176Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000250 AC: 6AN: 239654Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 129898
GnomAD4 exome AF: 0.000108 AC: 158AN: 1456878Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 78AN XY: 724318
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152176Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2022 | The c.130A>G (p.I44V) alteration is located in exon 2 (coding exon 2) of the AXL gene. This alteration results from a A to G substitution at nucleotide position 130, causing the isoleucine (I) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at